Sign in

CIK 0001806952

  • Non-accelerated filer
  • Smaller reporting company

Lyell Immunopharma, Inc.

Sign in to watch
Ticker
LYEL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
833006753
Phone
+1 650-695-0677
Business address
201 HASKINS WAY, SOUTH SAN FRANCISCO, CA, 94080
Open-market buys, last 90 days
$49,999,983
in 2 filings
Open-market sales, last 90 days
$215,781
in 9 filings

Net +$49,784,202. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 41 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-11-16 Hill Stephen J. Chief Technical Ops. Officer Returned to the company · Stock Option (right to buy) −165,000 0
2023-11-16 Hill Stephen J. Chief Technical Ops. Officer Grant or award · Stock Option (right to buy) +450,000 450,000
2023-11-16 Hill Stephen J. Chief Technical Ops. Officer Returned to the company · Stock Option (right to buy) −450,000 0
2023-11-16 Hill Stephen J. Chief Technical Ops. Officer Grant or award · Stock Option (right to buy) +100,000 100,000
2023-11-16 Hill Stephen J. Chief Technical Ops. Officer Returned to the company · Stock Option (right to buy) −100,000 0
2023-11-16 Hill Stephen J. Chief Technical Ops. Officer Grant or award · Stock Option (right to buy) +85,000 85,000
2023-11-16 Hill Stephen J. Chief Technical Ops. Officer Returned to the company · Stock Option (right to buy) −85,000 0
2023-11-16 Hill Stephen J. Chief Technical Ops. Officer Grant or award · Stock Option (right to buy) +700,000 700,000
2023-11-16 Hill Stephen J. Chief Technical Ops. Officer Returned to the company · Stock Option (right to buy) −700,000 0
2023-09-08 Klausner Richard Director Grant or award · Option (right to buy) +55,000 55,000
2023-09-08 RIEFLIN WILLIAM JL Director Grant or award · Option (right to buy) +55,000 55,000
2023-09-08 FRIEDMAN CATHY Director Grant or award · Option (right to buy) +55,000 55,000
2023-09-08 NELSEN ROBERT Director Grant or award · Option (right to buy) +55,000 55,000
2023-09-08 NABEL ELIZABETH G Director Grant or award · Option (right to buy) +55,000 55,000
2021-06-21 GLAXOSMITHKLINE PLC 10% owner Conversion +30,253,189 30,253,189
2021-06-21 GLAXOSMITHKLINE PLC 10% owner Conversion · Series AA Preferred Stock −30,253,189 0

Page 8 of 8 · 156 trades